European Medicines Agency updates on the review of Pandemrix and reports of narcolepsy

View source ↗

Summary

EMA provides updates on the review of Pandemrix and reports of narcolepsy, focusing on safety signals and ongoing assessment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Narcolepsy

Drugs mentioned

• Pandemrix (influenza vaccine (split virion, inactivated))